Sign in
BNGO Stock Price, Chart, Stats & News
Bionano Genomics, Inc.
Save
13.37M
Market cap
–
Current P/E
–
Forward P/E
BNGO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 21.95% |
Operating margin | -116.95% |
Pretax margin | -92.36% |
Net margin | -92.59% |
Effective tax rate | -0.25% |
ROA | -35.87% |
ROE | -56.22% |
D/E | 0.16x |
Interest coverage ratio | -144.95x |
BNGO valuation
P/E | – |
P/S | 0.13x |
P/B | 0.14x |
P/CF | -0.39x |
P/FCF | -0.23x |
P/OCF | -0.39x |
PEG | -0.00x |
EV multiple | 0.00x |
About
Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analysis of structural variations in the genome using optical genome mapping. This technology is vital for deciphering genetic variations and their functional roles.
Similar securities
Based on sector and market capitalization
Report issue